Evergreen Hematology/Oncology

Spokane, Washington 99218

0 studies enrolling now · 12 studies all time

What they study most

Breast Cancer Nos Metastatic Recurrent, Cancer, Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate, Cholangiocarcinoma, Colorectal Cancer, Hairy Cell Leukemia, Histiocytosis, Malignant Melanoma, Melanoma, Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer

Studies at this site

• Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer. — Stopped early
• Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer — Withdrawn before enrolling
• Safety Study of PLX108-01 in Patients With Solid Tumors — Completed
• A Phase I, Bioequivalence Study to Evaluate Two Formulations of Bendamustine (BDM) Hydrochloride (HCl) Administered to Cancer Patients — Completed
• Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers. — Stopped early
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas — Completed
• A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma — Completed
• A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors — Completed
• Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib — Completed
• Ixabepilone + Carboplatin Metastatic Breast Cancer — Completed
• FoundationOne™ Test Registry Study — Completed
• Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer — Status unconfirmed